Antibiotics: Decline in Prescriptions and Consumption by 2025
cp_atb_20261117.pdf
Download (PDF - 205.51 KB)
Press Contacts
Santé publique France
presse@santepubliquefrance.fr
Stéphanie Champion: 01 41 79 67 48
Marie Delibéros: 01 41 79 69 61
Camille Le Hyaric: 01 41 79 68 64
In observance of World Antimicrobial Resistance Awareness Week (November 18–24) and European Antibiotic Awareness Day (November 18), Santé publique France is releasing the latest data on antibiotic use and resistance in human healthcare.
Although they remain at a high level, antibiotic prescriptions and consumption in the outpatient sector decreased in 2025 compared to 2024, as well as over the 2015–2025 period.
Given the ongoing risk of the development of bacteria resistant to antibiotic treatment, it remains important to continue raising awareness among prescribing healthcare professionals and patients about the proper use of antibiotics.
The French are using fewer and fewer antibiotics
Data for 2025 shows a positive trend:
- Antibiotics consumed: down 9.6% compared to 2024.
- Antibiotics prescribed: down 13.9% compared to 2024, or 741 antibiotic prescriptions per 1,000 residents over the course of the year. This significant decline brings the country closer to the target of 650 prescriptions per 1,000 inhabitants per year by 2027, as set by the National Strategy for the Prevention of Infections and Antibiotic Resistance.
- France ranks 4th among the countries with the highest antibiotic consumption in Europe; this is an improvement over the previous year (2nd place in 2024).
In 2025, data on antibiotic prescriptions and consumption varied by patient age, gender, and region:
- Antibiotic consumption is generally higher among women than among men.
- The sharpest decline is among children aged 5 to 14.
- The least pronounced decline is among people aged 80 and older.
- Significant regional disparities in consumption persist: the lowest consumption rates are found in the Pays-de-Loire region and in Brittany, while the highest consumption rates are in Corsica and the PACA region.
More broadly, over the 2015–2025 period, the trend is also encouraging:
- A 17% decrease in consumption and a 23% decrease in prescriptions have been observed.
Antibiotic Resistance: A Mixed Picture
Antibiotics are effective only against bacterial infections and have no effect on infections caused by viruses. However, some bacteria become resistant due to the excessive or inappropriate use of antibiotics; they survive treatment and continue to multiply, even after antibiotics have been taken. This is known as antibiotic resistance. Infections then become harder to treat; treatments are longer, more intensive, and more expensive.
- In 2025 and for the past two years, Escherichia coli—the bacterium most commonly responsible for urinary tract infections—has become less resistant to fluoroquinolones (antibiotics primarily prescribed to treat these infections), both in community settings and in long-term care facilities.
- In contrast, enterobacteria (bacteria found in the intestine) are becoming increasingly resistant to carbapenems (reserve antibiotics prescribed when initial treatments prove ineffective): a 310% increase since 2019 in hospitals.
Antibiotics: How to Use Them Properly?
To combat antibiotic resistance, it is essential to continue raising patient awareness about the proper use of antibiotics:
- Antibiotics must be prescribed by a doctor before they can be taken. Since June 19, 2024, pharmacists have been able to dispense antibiotics without a prescription under certain conditions (a positive result from a rapid diagnostic test—TROD—and limited to cases of strep throat and urinary tract infections).
- The duration of antibiotic treatment must always be strictly followed.
- Any remaining antibiotics must be returned to the pharmacy.
- Never reuse antibiotics for yourself or your family members, even if the symptoms are the same.
To learn more about infections and antibiotics: www.antibiomalin.fr
See the publications at the following links
- Bulletin: Antibiotic Resistance and Antibiotic Use in 2025
- Report: Antibiotic Use in the Community Setting in France, 2015–2025
- Report: Surveillance of Antibiotic and Antifungal Use in Healthcare Facilities and Long-Term Care Facilities with an In-House Pharmacy, and of Bacterial Resistance in Healthcare Facilities. Key Findings for 2025 (SPARES National Mission)
- Report: Surveillance of bacterial resistance to antibiotics in outpatient care and long-term care facilities. Key findings for 2025 (PRIMO national initiative)
- BEH: Antibiotic Resistance in France in 2025: From Surveillance to Action
Our latest news
news
Call for Nominations to Fill Vacancies on the National Reference Centers...
news
Public Health France Conference: November 9, 2026
news